A Study of NGM282 in Patients With Primary Sclerosing Cholangitis

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

NCT06106672 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy

NCT04208828 ·Status: RECRUITING

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

NCT06866483 ·Status: RECRUITING

Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor

NCT03932864 ·Status: COMPLETED ·Phase: PHASE1

PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury

NCT04054414 ·Status: RECRUITING ·Phase: PHASE2

Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment

NCT06381284 ·Status: COMPLETED

A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

NCT06298552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis

NCT01532869 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy

NCT04025632 ·Status: TERMINATED ·Phase: PHASE2

A Prospective Cohort Study of Myasthenia Gravis in China

NCT06006832 ·Status: RECRUITING

A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body

NCT03241264 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG

NCT06892288 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Prospective Study of Celiac Block Injection: 1 vs. 2

NCT00583479 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects

NCT02703051 ·Status: COMPLETED ·Phase: PHASE1

Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis

NCT01828294 ·Status: TERMINATED ·Phase: PHASE1

A Phase I Safety Study of NVG-291 in Healthy Adults

NCT05308953 ·Status: COMPLETED ·Phase: PHASE1

Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)

NCT04450654 ·Status: WITHDRAWN ·Phase: PHASE2

Pyridostigmine and Amifampridine for Myasthenia Gravis

NCT05919407 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis

NCT02473952 ·Status: COMPLETED ·Phase: PHASE2

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

NCT03052751 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

NCT05092841 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

NCT06704269 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

NCT00727194 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome

NCT04752566 ·Status: COMPLETED ·Phase: PHASE3

Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies

NCT00001261 ·Status: COMPLETED ·Phase: PHASE2